ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Novartis has inaugurated new R&D buildings and labs in Shanghai. The expansion of the Novartis Institutes for BioMedical Research in Shanghai will provide space for as many as 1,300 scientists, up from 500 previously. Research at the center focuses on infections that lead to cancer in Asian patients. In addition, scientists at the center perform discovery chemistry and biomarker research. Separately, AkzoNobel opened its largest R&D center in China, also in Shanghai. The Dutch firm invested more than $7 million in the facility, which employs 150 scientists focusing on coatings and specialty chemicals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter